Evidence-Based Management of Heart Failure & High Cholesterol

Evidence-Based Management of Heart Failure & High Cholesterol is organized by University of Texas at Austin College of Pharmacy.,Release Date: 12/20/2021,Expiration Date: 12/20/2023,Program Overview:,The prevalence of heart failure (HF) has increased from 5.7 million to 6.5 million Americans, contributing to one in eight deaths and accounting for almost 400,000 deaths each year. High cholesterol currently affects 99 million Americans or 45% of the adult population.1,2 Not only is it important for clinicians to understand how these diseases will impact their patients, but they must also be able to navigate the ever-evolving landscape of evidence-based therapeutics that are available for treatment. Recent treatment developments plus guideline updates for both HF and high cholesterol has given clinicians more information and data than ever before to consider when caring for their patients. This activity will help pharmacists, physicians, physician assistants, and nurses to review the effects of heart failure and high cholesterol and to develop evidence-based treatment plans for their patients.,Program Goal:,The overall goal is to enhance participants' knowledge about heart failure, high cholesterol, and the variety of therapeutics that are available to treat these conditions. In addition, participants will also learn how to navigate evolving evidence, research, and guidelines that must be considered when using these therapeutics in clinical practice.